Quantum-Si incorporated

NasdaqGM QSI

Quantum-Si incorporated Price to Book Ratio (P/B) on January 14, 2025: 1.33

Quantum-Si incorporated Price to Book Ratio (P/B) is 1.33 on January 14, 2025, a 67.23% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Quantum-Si incorporated 52-week high Price to Book Ratio (P/B) is 3.13 on January 07, 2025, which is 136.29% above the current Price to Book Ratio (P/B).
  • Quantum-Si incorporated 52-week low Price to Book Ratio (P/B) is 0.37 on November 19, 2024, which is -71.90% below the current Price to Book Ratio (P/B).
  • Quantum-Si incorporated average Price to Book Ratio (P/B) for the last 52 weeks is 0.75.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
NasdaqGM: QSI

Quantum-Si incorporated

CEO Mr. Jeffrey Alan Hawkins
IPO Date Nov. 13, 2020
Location United States
Headquarters 530 Old Whitfield Street
Employees 159
Sector Health Care
Industries
Description

Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.

Similar companies

SEER

Seer, Inc.

USD 2.29

-1.29%

RNA

Avidity Biosciences, Inc.

USD 27.05

-4.79%

NRIX

Nurix Therapeutics, Inc.

USD 18.60

-2.16%

PRME

Prime Medicine, Inc.

USD 2.70

-2.53%

MNOV

MediciNova, Inc.

USD 1.91

-4.02%

VERV

Verve Therapeutics, Inc.

USD 5.25

-4.54%

HRTX

Heron Therapeutics, Inc.

USD 1.47

-4.54%

BDTX

Black Diamond Therapeutics, Inc.

USD 2.25

-2.60%

HOOK

HOOKIPA Pharma Inc.

USD 1.86

4.49%

NTLA

Intellia Therapeutics, Inc.

USD 9.74

-3.08%

EDIT

Editas Medicine, Inc.

USD 1.14

-1.72%

BEAM

Beam Therapeutics Inc.

USD 23.30

-8.77%

CRBU

Caribou Biosciences, Inc.

USD 1.56

0.65%

ALEC

Alector, Inc.

USD 1.64

-8.38%

ABOS

Acumen Pharmaceuticals, Inc.

USD 1.56

-1.89%

CRSP

CRISPR Therapeutics AG

USD 38.36

-1.26%

StockViz Staff

January 15, 2025

Any question? Send us an email